Founded and led by Ralph Bossino in 2018 to identify and invest in specialty biopharmaceutical advancements utilizing phytochemicals, with a scientific and evidential basis, for therapeutic use to benefit patients worldwide, focusing on strategic investments in leading companies in Israel, UK, and Canada.